Subjective: A patient presents to your primary care office today with chief complaint of insomnia. Patient is 75 YO with PMH of DM, HTN, and MDD. Her husband of 41 years passed away 10 months ago. Since then, she states her depression has gotten worse as well as her sleep habits. The patient has no previous history of depression prior to her husband’s death. She is awake, alert, and oriented x3. Patient normally sees PCP once or twice a year. Patient denies any suicidal ideations. Patient arrived at the office today by private vehicle. Patient currently takes the following medications:
• Metformin 500mg BID
• Januvia 100mg daily
• Losartan 100mg daily
• HCTZ 25mg daily
• Sertraline 100mg daily
Current weight: 88 kg
Current height: 64 inches
Temp: 98.6 degrees F
BP: 132/86
BY DAY 3 OF WEEK 7
Post a response to each of the following:
• List three questions you might ask the patient if she were in your office. Provide a rationale for why you might ask these questions.
• Identify people in the patient’s life you would need to speak to or get feedback from to further assess the patient’s situation. Include specific questions you might ask these people and why.
• Explain what, if any, physical exams, and diagnostic tests would be appropriate for the patient and how the results would be used.
• List a differential diagnosis for the patient. Identify the one that you think is most likely and explain why.
• List two pharmacologic agents and their dosing that would be appropriate for the patient’s antidepressant therapy based on pharmacokinetics and pharmacodynamics. From a mechanism of action perspective, provide a rationale for why you might choose one agent over the other.
• For the drug therapy you select, identify any contraindications to use or alterations in dosing that may need to be considered based on ethical prescribing or decision-making. Discuss why the contraindication/alteration you identify exists. That is, what would be problematic with the use of this drug in individuals based on ethical prescribing guidelines or decision-making?
• Include any “check points” (i.e., follow-up data at Week 4, 8, 12, etc.), and indicate any therapeutic changes that you might make based on possible outcomes that may happen given your treatment options chosen.
Case: An elderly widow who just lost her spouse.
Full Answer Section
People to Speak To:
- Close friends or family: (Ask about observed changes in mood, behavior, social engagement, and daily functioning. Inquire about support networks and potential concerns they might have.)
- Previous healthcare providers: (Request medical records and previous treatment plans for depression or other relevant conditions.)
Physical Exams and Diagnostic Tests:
- Physical examination: (Assess vital signs, thyroid function, and any potential medical contributors to insomnia or depression.)
- Thyroid function tests: (Hypothyroidism can mimic symptoms of depression and insomnia.)
- Sleep study: (May be considered in severe cases to rule out sleep apnea or other sleep disorders.)
Differential Diagnosis:
- Major depressive disorder: Most likely diagnosis given the presenting symptoms and recent bereavement.
- Adjustment disorder with depressed mood: May be considered if symptoms are primarily related to the loss and resolve within 6 months.
- Generalized anxiety disorder: Less likely but possible if anxiety is the predominant symptom interfering with sleep.
- Sleep apnea: Uncommon at this age but should be considered if physical exam or history suggests risk factors.
Pharmacologic Agents:
- Mirtazapine 15mg nightly: Has sedative and appetite-stimulating properties, potentially improving sleep and addressing weight loss.
- Escitalopram 10mg daily: Selective serotonin reuptake inhibitor (SSRI) with minimal side effects and good tolerability in older adults.
Rationale for Selection: Mirtazapine's sedative effect and ability to increase appetite might be beneficial for this patient's specific needs, though escitalopram's tolerability and safety in older adults are also important considerations.
Contraindications and Dosing Alterations:
- Mirtazapine: Hypotension risk – Monitor blood pressure closely. Start with lower dose and titrate slowly.
- Escitalopram: QTc prolongation risk in older adults – Monitor EKG and electrolytes. Consider lower initial dose.
Follow-up and Therapeutic Changes:
- Week 4: Assess sleep quality, mood, and overall well-being. Consider dose adjustment if needed.
- Week 8: Evaluate response to treatment. Monitor for potential side effects.
- Week 12: Continue monitoring progress, adjust medication or therapy as needed. Address any unresolved grief or persistent symptoms.
Additional Points:
- Consider referral to psychotherapy for grief counseling and cognitive-behavioral therapy for insomnia.
- Encourage healthy sleep hygiene practices and exercise.
- Provide support resources for bereavement and mental health services.
Sample Answer
Patient Questions:
- Describe your typical sleep schedule before and after your husband's passing. (Rationale: Assess baseline sleep patterns and identify any changes in duration, quality, or sleep habits associated with the bereavement.)
- What activities or thoughts typically keep you awake at night? (Rationale: Identify potential contributing factors to insomnia, such as anxiety, rumination, or grief-related thoughts.)
- Have you noticed any changes in your appetite, energy levels, or motivation since your husband's death? (Rationale: Screen for broader depressive symptoms beyond insomnia and assess overall emotional well-being.)